Log in or Sign up for Free to view tailored content for your specialty!
Ophthalmology News
BLOG: Rollover equity: Linking arms with your private equity partner
As we discussed in our overview of the private equity, or PE, physician practice model, the buyer in an acquisition is often a PE-sponsored management services organization that purchases the nonclinical aspects of the practice’s business.
VIDEO: Detecting, managing diabetic eye disease in pregnancy
In this video, Diana Do, MD, discusses the importance of multidisiplinary care in managing patients with diabetic eye diseases.
Log in or Sign up for Free to view tailored content for your specialty!
No spondyloarthritis screening tools generalizable to all at-risk patients
Screening patients with psoriasis, uveitis or inflammatory bowel disease for spondyloarthritis could improve early diagnosis, but no existing screening tools are generalizable to all who are at risk, according to a scoping review.
'You're not going crazy': Second annual primary care scorecard highlights critical issues
The results of the second annual national primary care scorecard suggest the field is facing major problems — poor funding and a diminishing workforce, among them — but increased attention on the issues may offer hope, according to experts.
BLOG: If sitting is the new smoking, should apps have warnings like cigarette packages?
For most of us doctors, it’s the last thing we look at before bed and the first thing when we wake up: the screen of our smartphone or tablet.
Q&A: What PCPs need to know about thyroid eye disease
Primary care providers can play an important role in the management of an often-overlooked disorder, thyroid eye disease, according to an expert.
FDA approves Abrilada as second interchangeable adalimumab biosimilar
The FDA has approved Abrilada as the second interchangeable biosimilar to adalimumab, according to a press release from Pfizer.
The Latest News and Notes, plus Conversation with Julia Haller, MD
Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Julia Haller, MD, about the latest developments in retina, residency training and more.
Amgen clear to acquire Horizon after agreement with Federal Trade Commission
Amgen has reached a deal with the Federal Trade Commission that will enable the pharmaceutical company to complete its $28 billion acquisition of Horizon, according to statements from both parties.
Study: Vision testing rates at well-child visits low in US
Despite guidelines recommending yearly testing, the probability of receiving a vision test from a primary care physician was low in youth and varied by insurance status, a recent study found.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read